Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03039231 · ClinicalTrials.gov registry record · NA

Investigation of the Freespira Breathing System in the Treatment of Post Traumatic Stress Disorder (PTSD)

A NA study of Stress Disorders, Post-Traumatic, sponsored by Palo Alto Health Sciences.

Completed
Registry status
NA
Development phase
55
Enrollment target
1
Study location

NCT03039231 is a NA study of Stress Disorders, Post-Traumatic that has completed, run by Palo Alto Health Sciences. The registered enrollment target is 55 participants, below the 155-participant average among 64 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03039231, a NA study of Stress Disorders, Post-Traumatic, has completed, sponsored by Palo Alto Health Sciences.

COMPLETED
Registry status
NA
Development phase
55 participants
Enrollment target
1
Study location

Study Summary

This study will test the efficacy of the Freespira Breathing System in adults with post traumatic stress disorder (PTSD).

Interventions

  • DEVICE Freespira Breathing System

Study Locations (1)

California

  • Stanford University School of Medicine/Palo Alto Veterans Institute for Research - Palo Alto

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2017-02-01
Est. Completion 2019-08-25
Phase NA

Sponsor

Palo Alto Health Sciences

2 total trials

What the Registry Record Tells You About NCT03039231

The ClinicalTrials.gov registry entry for NCT03039231 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 155-participant average among 64 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (65% lower). The listed sponsor is Palo Alto Health Sciences, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 1 intervention - of which Freespira Breathing System is the first listed.

NCT03039231 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03039231 about?

NCT03039231 is a clinical study titled "Investigation of the Freespira Breathing System in the Treatment of Post Traumatic Stress Disorder (PTSD)". This study will test the efficacy of the Freespira Breathing System in adults with post traumatic stress disorder (PTSD).

What is the current status of trial NCT03039231?

This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2017-02-01. Estimated completion is 2019-08-25.

What conditions does trial NCT03039231 study?

This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic.

What interventions are being tested in trial NCT03039231?

The interventions under investigation include: Freespira Breathing System (DEVICE).

Who is sponsoring clinical trial NCT03039231?

This trial is sponsored by Palo Alto Health Sciences, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03039231 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress Disorders, Post-Traumatic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.